FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

AOC doubles down on call for Trump’s ouster even after ceasefire announcement

Inside Antifa-linked group’s plan to ‘structurally change’ the US as May Day unrest approaches

Michigan Senate hopeful Abdul El-Sayed’s unapologetic embrace of Hasan Piker

Terror suspects indicted after allegedly throwing bombs at NYC protest outside mayor’s mansion

A-10 Warthog given new maritime role targeting boats in Iran after efforts to retire aircraft

Breaking: Oil Plummets After Trump Announces Iran Ceasefire

Abortion pill mifepristone stays available by mail for now as FDA faces 6-month review deadline

Pope Leo calls out Trump’s Iran rhetoric before last-minute ceasefire emerges

Liberals tighten grip on battleground state Supreme Court in low-key but high-stakes election

American couple chasing retirement dream in Bahamas boating mystery were ‘inexperienced’: Friend

Swalwell campaign rejects ‘outrageous’ allegations of sexual misconduct as Dem activists issue viral warning

Watch: The Country Would ‘Come Unglued’ – Tim Burchett Reveals Alien Life Briefing He Attended 2 Weeks Ago

Texas man tackled by church security after bringing loaded gun, ammo to Houston service

ESPN Set to Begin Layoffs Due to ‘Unexpected Revenue Dip’: Report

Trump-backed Republican pads GOP’s fragile House majority by winning showdown for MTG’s former seat

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”